Joe Bonaccorso
Corporate Officer/Principal bei VERRICA PHARMACEUTICALS INC.
Vermögen: 783 761 $ am 31.03.2024
Profil
Joe Bonaccorso is currently the Chief Commercial Officer at Verrica Pharmaceuticals, Inc. He previously worked as a Principal at Novartis Pharmaceuticals Corp.
Mr. Bonaccorso completed his undergraduate degree at Fairleigh Dickinson University in 1985 and obtained an MBA from Kean University in 1993.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.03.2024 | 132 392 ( 0,31% ) | 783 761 $ | 31.03.2024 |
Aktive Positionen von Joe Bonaccorso
| Unternehmen | Position | Beginn |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.02.2018 |
Ehemalige bekannte Positionen von Joe Bonaccorso
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Ausbildung von Joe Bonaccorso
| Fairleigh Dickinson University | Undergraduate Degree |
| Kean University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
